Showing results (151-160 of 339) with videos related to
Sort By:
Pageof 34
Transplantation and Cellular Therapy|October 12, 2020
Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023Nosha Farhadfar, Linda J Burns, Tatenda Mupfudze, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2011
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of AmericaAlison G Freifeld, Eric J Bow, Kent A Sepkowitz, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcomeThomas F Patterson, Helen W Boucher, Raoul Herbrecht, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2011
Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant ResearchNaynesh R Kamani, Shimareet Kumar, Anna Hassebroek, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myelomaRavi Vij, Shaji Kumar, Mei-Jie Zhang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2007
Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survivalMary Eapen, Brent R Logan, Dennis L Confer, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2002
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II studyBorje S Andersson, Ashwin Kashyap, Victor Gian, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2016
Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902)John R Wingard, William A Wood, Michael Martens, et al.Stem Cells Translational Medicine|December 10, 2023
A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Non-HLA Matched, Unrelated Donor, Cord Blood Infusion for Ischemic StrokeDaniel T Laskowitz, Jesse Troy, Emily Poehlein, et al.Leukemia Research|May 2, 2016
A new model to predict remission status in AML patients based on day 14 bone marrow biopsyMaxim Norkin, Myron Chang, Qi An, et al.Pageof 34